Ryan N. Hansen

2.6k total citations · 1 hit paper
102 papers, 1.9k citations indexed

About

Ryan N. Hansen is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Ryan N. Hansen has authored 102 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Economics and Econometrics, 22 papers in Public Health, Environmental and Occupational Health and 21 papers in Surgery. Recurrent topics in Ryan N. Hansen's work include Health Systems, Economic Evaluations, Quality of Life (16 papers), Opioid Use Disorder Treatment (15 papers) and Anesthesia and Pain Management (10 papers). Ryan N. Hansen is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (16 papers), Opioid Use Disorder Treatment (15 papers) and Anesthesia and Pain Management (10 papers). Ryan N. Hansen collaborates with scholars based in United States, United Kingdom and Netherlands. Ryan N. Hansen's co-authors include Emily Beth Devine, Patrick Gillard, Zsolt Hepp, Sepideh F. Varon, David W. Dodick, Sean D. Sullivan, Jenny Chia, George J. Wan, Jonathan D. Campbell and Laura S. Gold and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Ryan N. Hansen

98 papers receiving 1.8k citations

Hit Papers

Adherence to oral migraine-preventive medications among p... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan N. Hansen United States 21 695 492 333 240 231 102 1.9k
George J. Wan United States 25 721 1.0× 94 0.2× 471 1.4× 325 1.4× 214 0.9× 91 2.4k
Kenneth Brummel‐Smith United States 21 273 0.4× 137 0.3× 279 0.8× 453 1.9× 247 1.1× 52 2.4k
Maria M. Wertli Switzerland 25 438 0.6× 648 1.3× 669 2.0× 207 0.9× 237 1.0× 101 2.5k
M Abdalla United Kingdom 11 184 0.3× 189 0.4× 661 2.0× 165 0.7× 299 1.3× 14 2.6k
Petra Jellema Netherlands 23 258 0.4× 411 0.8× 393 1.2× 137 0.6× 91 0.4× 36 1.9k
Marcia F.T. Rupnow United States 28 1.6k 2.3× 730 1.5× 498 1.5× 77 0.3× 410 1.8× 63 2.6k
S. Bolge United States 22 217 0.3× 91 0.2× 525 1.6× 137 0.6× 437 1.9× 68 2.3k
Bethan Copsey United Kingdom 18 425 0.6× 101 0.2× 171 0.5× 245 1.0× 142 0.6× 40 1.6k
Janet K. Freburger United States 21 418 0.6× 642 1.3× 358 1.1× 280 1.2× 156 0.7× 45 2.4k
Bernd Schweikert Germany 16 176 0.3× 329 0.7× 127 0.4× 125 0.5× 140 0.6× 37 1.4k

Countries citing papers authored by Ryan N. Hansen

Since Specialization
Citations

This map shows the geographic impact of Ryan N. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan N. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan N. Hansen more than expected).

Fields of papers citing papers by Ryan N. Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan N. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan N. Hansen. The network helps show where Ryan N. Hansen may publish in the future.

Co-authorship network of co-authors of Ryan N. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan N. Hansen. A scholar is included among the top collaborators of Ryan N. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan N. Hansen. Ryan N. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gold, Laura S., Patrick J. Heagerty, Ryan N. Hansen, et al.. (2025). Adverse respiratory events during treatment with gabapentin and opioids among older adults with spine-related conditions: a propensity-matched cohort study in the US Medicare population. The Spine Journal. 25(9). 2096–2107. 1 indexed citations
3.
Green, Traci C., Anthony S. Floyd, Adriane N. Irwin, et al.. (2023). Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains. Journal of the American Pharmacists Association. 64(1). 71–78. 2 indexed citations
4.
Gold, Laura S., et al.. (2023). Antidepressants and the Risk of Fall-Related Injury in Older Adults with Incident Depression in the United States: A Comparative Safety Analysis. SHILAP Revista de lepidopterología. 2(3). 209–222. 1 indexed citations
5.
Gold, Laura S., Ryan N. Hansen, Sonya L. Heltshe, et al.. (2023). Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location. Journal of Cystic Fibrosis. 23(2). 278–281. 2 indexed citations
6.
Seslar, Stephen P., et al.. (2022). Health care resource utilization and costs associated with atrial fibrillation and rural-urban disparities. Journal of Managed Care & Specialty Pharmacy. 28(11). 1321–1330. 14 indexed citations
7.
Irwin, Adriane N., Jeffrey Bratberg, Anthony S. Floyd, et al.. (2022). Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician. Journal of the American Pharmacists Association. 63(1). 284–294.e1. 10 indexed citations
8.
Floyd, Anthony S., Adriane N. Irwin, Jeffrey Bratberg, et al.. (2022). Readiness of community pharmacies to implement an opioid safety intervention. Journal of the American Pharmacists Association. 63(1). 275–283.e1. 8 indexed citations
9.
Hansen, Ryan N., et al.. (2021). Opportunities and Barriers to Rural Telerobotic Surgical Health Care in 2021: Report and Research Agenda from a Stakeholder Workshop. Telemedicine Journal and e-Health. 28(7). 1050–1057. 8 indexed citations
10.
Hansen, Ryan N., et al.. (2021). Health care costs related to home spirometry in the eICE randomized trial. Journal of Cystic Fibrosis. 21(1). 61–69. 4 indexed citations
11.
Wright, Jonathan L., et al.. (2020). Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing. Academic Pathology. 7. 1534968353–1534968353. 2 indexed citations
12.
Barrington, John W., Ryan N. Hansen, Belinda Lovelace, et al.. (2018). Impact of Intravenous Acetaminophen on Lengths of Stay and Discharge Status after Total Knee Arthroplasty. The Journal of Knee Surgery. 32(1). 111–116. 10 indexed citations
13.
Keyloun, Katelyn R., Ryan N. Hansen, Zsolt Hepp, et al.. (2017). Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD). CNS Drugs. 31(5). 421–432. 65 indexed citations
14.
15.
Hansen, Ryan N., An T. Pham, E. Boing, et al.. (2017). Hospitalization costs and resource allocation in cholecystectomy with use of intravenous versus oral acetaminophen. Current Medical Research and Opinion. 34(9). 1549–1555. 9 indexed citations
17.
Hansen, Ryan N., et al.. (2015). Mortality And Readmission In Mechanically Ventilated Patients With Pneumonia. Value in Health. 18(3). A169–A170. 2 indexed citations
18.
Hackshaw, Michelle D., Ryan N. Hansen, Saurabh Nagar, et al.. (2014). Costs Associated with Health Care Resource Use in Patients with Advanced Renal Cell Carcinoma Receiving First-Line Treatment with Pazopanib Versus Sunitinib. Value in Health. 17(3). A77–A78. 1 indexed citations
20.
Carlson, Josh J., Ryan N. Hansen, Roger R. Dmochowski, et al.. (2013). Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States. Clinical Therapeutics. 35(4). 414–424. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026